Eyelash serums: A comprehensive review
- PMID: 38475901
- DOI: 10.1111/jocd.16278
Eyelash serums: A comprehensive review
Abstract
Background: Eyelash serums, both prescription and over-the-counter, are gaining popularity for enhancing the appearance of eyelashes through various biologically active molecules. Categorized into prostaglandin analogs and non-prostaglandin analogs, these serums claim increased strength, length, luster, and thickness. Current United States law also requires no efficacy or safety assessments by the Food and Drug Administration before approving products for consumer use, potentially posing health risks for patients seeking over-the-counter eyelash enhancements.
Aims: Our aims include exploring proposed benefits and adverse effects associated with eyelash serums, while providing evidence-based clinical recommendations on their use. We aim to contribute valuable insights to the understanding of eyelash serums and their respective safety considerations.
Methods: The authors conducted a comprehensive electronic search across databases including PubMed, Embase, Cochrane Central, and Google Scholar to evaluate eyelash serum ingredients. Articles were evaluated by two independent researchers for relevance, and the ingredients discussed were analyzed and given clinical recommendations for eyelash serums based off the Oxford Centre for Evidence-Based Medicine.
Results: Results highlight bimatoprost's efficacy, supported by numerous studies evaluating safety and adverse effects. Other prostaglandin ingredients show potential benefits, but further studies are encouraged to enhance the understanding of respective safety profiles. While non-prostaglandins ingredients show promising data, more studies are needed due to a lack of formal evidence in eyelash serum use.
Conclusion: As the cosmeceutical market for eyelash serums is growing, dermatologists need to be knowledgeable about evidence-based information regarding prescription and over-the-counter eyelash serum products before making recommendations to patients.
Keywords: eyelash growth; eyelash serum; hair growth; serum.
© 2024 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Similar articles
-
Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.Dermatol Surg. 2021 May 1;47(5):658-665. doi: 10.1097/DSS.0000000000002928. Dermatol Surg. 2021. PMID: 33625141 Review.
-
Enhanced eyelashes: prescription and over-the-counter options.Aesthetic Plast Surg. 2011 Feb;35(1):116-21. doi: 10.1007/s00266-010-9561-3. Epub 2010 Aug 21. Aesthetic Plast Surg. 2011. PMID: 20730536 Free PMC article. Review.
-
Adverse periocular reactions to five types of prostaglandin analogs.Eye (Lond). 2012 Nov;26(11):1465-72. doi: 10.1038/eye.2012.195. Epub 2012 Oct 5. Eye (Lond). 2012. PMID: 23037910 Free PMC article.
-
Screening and quantification of undeclared PGF2α analogs in eyelash-enhancing cosmetic serums using LC-MS/MS.J Pharm Biomed Anal. 2022 Sep 20;219:114940. doi: 10.1016/j.jpba.2022.114940. Epub 2022 Jul 14. J Pharm Biomed Anal. 2022. PMID: 35882176
-
Bimatoprost in the treatment of eyelash hypotrichosis.Clin Ophthalmol. 2010 Apr 26;4:349-58. doi: 10.2147/opth.s6480. Clin Ophthalmol. 2010. PMID: 20463804 Free PMC article.
Cited by
-
Cancer-Related Alopecia Risk and Treatment.Curr Treat Options Oncol. 2025 Aug;26(8):706-715. doi: 10.1007/s11864-025-01336-2. Epub 2025 Jul 14. Curr Treat Options Oncol. 2025. PMID: 40658349 Free PMC article. Review.
References
REFERENCES
-
- Law SK. Bimatoprost in the treatment of eyelash hypotrichosis. Clin Ophthalmol. 2010;4:349‐358.
-
- Corea D. Eyelash serum market to reach $1.3 BN, globally, by 2031 at 5.7% CAGR: allied market research. PR Newswire. 2022.
-
- Aumond S, Bitton E. The eyelash follicle features and anomalies: a review. J Optom. 2018;11(4):211‐222.
-
- Thibaut S, De Becker E, Caisey L, et al. Human eyelash characterization. Br J Dermatol. 2010;162(2):304‐310.
-
- Na JI, Kwon OS, Kim BJ, et al. Ethnic characteristics of eyelashes: a comparative analysis in Asian and Caucasian females. Br J Dermatol. 2006;155(6):1170‐1176.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials